Clinical Trial Update: A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants. [Phase 1]

View source ↗

Summary

This Phase 1 single ascending-dose trial evaluated the pharmacokinetics, safety, and tolerability of SAR441566 in healthy adult Japanese male participants. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED